PRLD Stock Overview
Prolight Diagnostics AB (publ) entwickelt Diagnosesysteme, die in Schweden für Tests am Point of Care eingesetzt werden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Prolight Diagnostics AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.18 |
| 52 Week High | kr0 |
| 52 Week Low | kr0 |
| Beta | 2.54 |
| 1 Month Change | 4.09% |
| 3 Month Change | -33.08% |
| 1 Year Change | -44.38% |
| 3 Year Change | -88.55% |
| 5 Year Change | -78.29% |
| Change since IPO | -51.76% |
Recent News & Updates
Recent updates
Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?
Jul 14
Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth
Nov 07We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth
Jul 06Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth
Mar 09Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans
Nov 24Shareholder Returns
| PRLD | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.8% | -0.9% | -0.8% |
| 1Y | -44.4% | -8.0% | 13.0% |
Rendite im Vergleich zur Industrie: PRLD unter dem Niveau der Branche Swedish Medical Equipment , die im vergangenen Jahr eine Rendite von -5.2% erzielte.
Rendite vs. Markt: PRLD hinter dem Markt Swedish zurück, der im vergangenen Jahr eine Rendite von 0.9 erzielte.
Price Volatility
| PRLD volatility | |
|---|---|
| PRLD Average Weekly Movement | 11.5% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.4% |
| 10% least volatile stocks in SE Market | 3.5% |
Stabiler Aktienkurs: PRLDDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: PRLDDie wöchentliche Volatilität der Aktie ist im vergangenen Jahr von 18% auf 13% gesunken, liegt aber immer noch über 75% der Aktien von Swedish.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 6,069 | Ulf Bladin | https://prolightdiagnostics.se |
Prolight Diagnostics AB (publ) entwickelt Diagnosesysteme, die in Schweden für Point-of-Care-Tests eingesetzt werden. Das Unternehmen beschäftigt sich mit der Entwicklung von PLD-Mikroflex und Flexmembran. Prolight Diagnostics AB (publ) wurde 1999 gegründet und hat seinen Sitz in Stockholm, Schweden.
Prolight Diagnostics AB (publ) Fundamentals Summary
| PRLD fundamental statistics | |
|---|---|
| Market cap | kr88.96m |
| Earnings (TTM) | -kr27.75m |
| Revenue (TTM) | kr18.68m |
4.8x
P/S Ratio-3.2x
P/E RatioIs PRLD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRLD income statement (TTM) | |
|---|---|
| Revenue | kr18.68m |
| Cost of Revenue | kr0 |
| Gross Profit | kr18.68m |
| Other Expenses | kr46.43m |
| Earnings | -kr27.75m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.056 |
| Gross Margin | 100.00% |
| Net Profit Margin | -148.53% |
| Debt/Equity Ratio | 0% |
How did PRLD perform over the long term?
See historical performance and comparison